These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 30195142)

  • 1. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
    Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW7 inhibited cell proliferation and invasion regulated by miR-27a through PI3K/AKT signaling pathway and epithelial-to-mesenchymal transition in oral squamous cell carcinoma.
    Li C; Lin XF; Wang JN; Ren XS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3701-3709. PubMed ID: 32329846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
    Fan QC; Tian H; Wang Y; Liu XB
    Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
    Yang G; Yang Y; Tang H; Yang K
    Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.
    Wei M; Wu Y; Liu H; Xie C
    Drug Des Devel Ther; 2020; 14():395-405. PubMed ID: 32099325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells.
    Lau MT; Leung PC
    Cancer Lett; 2012 Dec; 326(2):191-8. PubMed ID: 22922215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.
    Sun Y; Yang X; Guan S; Ma T; Jiang Z; Gao M; Xu Y; Cong B
    Arch Oral Biol; 2023 Dec; 156():105810. PubMed ID: 37852106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
    Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
    Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
    He W; Lai R; Lin Q; Huang Y; Wang L
    J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin nanoemulsions inhibit oral squamous cell carcinoma cell proliferation by PI3K/Akt/mTOR suppression and miR-199a upregulation: A preliminary study.
    Liu W; Wang J; Zhang C; Bao Z; Wu L
    Oral Dis; 2023 Nov; 29(8):3183-3192. PubMed ID: 35689522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway.
    Guo W; Qu Y; Yu Y; Li X; Liang Z; Wang Z; Hu T; Zhou S
    Aging (Albany NY); 2024 May; 16(10):9204-9215. PubMed ID: 38795388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.